Spectacle independence and subjective satisfaction of ReSTOR® multifocal intraocular lens after cataract or presbyopia surgery in two European countries

Clinical Ophthalmology

Volumn 4, Issue 1, 2010, Pages 81-89

  Cochener, Béatrice ^a   Fernández Vega, Luis ^b   Alfonso, Jose F ^b   Maurel, Frédérique ^c   Meunier, Juliette ^d   Berdeaux, Gilles ^e,f  

^a Centre hospitalier de Brest   (France)

^b Instituto Oftalmologico Fernandez Vega   (Spain)

^c IQVIA   (United States)

^d MAPI VALUES   (United States)

^e Alcon France   (France)

^f University of Paris Cité   (France)

Author keywords

Cataract surgery; Multifocal intraocular lens; Patient satisfaction; Spectacles independence

Indexed keywords

ADULT; AGED; ARTICLE; CATARACT; FEMALE; FRANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIFOCAL LENS; PATIENT SATISFACTION; PHACOEMULSIFICATION; PREDICTION; PRESBYOPIA; PSYCHOLOGICAL ASPECT; SPAIN; SPECTACLES; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 77953404468     PISSN: 11775467     EISSN: 11775483     Source Type: Book Series    
DOI: None     Document Type: Article

References (36)

1. Simpson MJ. The diffractive multifocal intraocular lens. Eur J Implant Refract Surf. 1989;1:115-121.
2. Leyland M, Pringle E. Multifocal versus monofocal intraocular lenses after cataract extraction. Cochrane Database Syst Rev. 2006 Oct 18;(4): CD003169.
3. Davison JA, Simpson MJ. History and development of the apodized diffractive intraocular lens. J Cataract Refract Surg. 2006;32:849-858.
4. Blaylock JF, Si Z, Vickers C. Visual and refractive status at different focal distances after implantation of the ReSTOR® multifocal intraocular lens. J Cataract Refract Surg. 2006;32:1464-1473.
5. Chiam PJ, Chan JH, Aggarwal RK, Kasaby S. ReSTOR® intraocular lens implantation in cataract surgery: quality of vision. J Cataract Refract Surg. 2006;32:1459-1463.
6. Souza CE, Gerente VM, Chalita MR, Soriano ES, Freitas LL, Belfort R Jr. Visual acuity, contrast sensitivity, reading speed, and wavefront analysis: pseudophakic eye with multifocal IOL (ReSTOR®) versus fellow phakic eye in non-presbyopic patients. J Refract Surg. 2006;22:303-305.
7. Souza CE, Muccioli C, Soriano ES, et al. Visual performance of AcrySof ReSTOR® apodized diffractive IOL: a prospective comparative trial. Am J Ophthalmol. 2006;141:827-832.
8. Kohnen T, Allen D, Boureau C, et al. European multicenter study of the AcrySof ReSTOR® apodized diffractive intraocular lens. Ophthalmology. 2006;113:584.e1.
9. Cuq C, Spera C, Laurendeau C, Lafuma A, Berdeaux G. Intermediate visual acuity without spectacles following bilateral ReSTOR® implantation. Eur J Ophthalmol. 2008;18:733-738.
10. de Vries NE, Franssen L, Webers CA, et al. Intraocular straylight after implantation of the multifocal AcrySof ReSTOR® SA60D3 diffractive intraocular lens. J Cataract Refract Surg. 2008;34:957-962.
11. Chang DF. Prospective functional and clinical comparison of bilateral ReZoom and ReSTOR® intraocular lenses in patients 70 years or younger. J Cataract Refract Surg. 2008;34:934-941.
12. Blaylock JF, Si Z, Aitchison S, Prescott C. Visual function and change in quality of life after bilateral refractive lens exchange with the ReSTOR® multifocal intraocular lens. J Refract Surg. 2008;24:265-273.
13. Berdeaux G, Viala M, Roborel de Climens A, Arnould B. Patientreported benefit of ReSTOR® multi-focal intraocular lenses after cataract surgery: results of principal component analysis on clinical trial data. Health Qual Life Outcomes. 2008;24:6-10.
14. Bi H, Cui Y, Ma X. et al Early clinical evaluation of AcrySof ReSTOR® multifocal intraocular lens for treatment of cataract. Ophthalmologica. 2008;222:11-16.
15. Chiam PJ, Chan JH, Haider SI, Karia N, Kasaby H, Aggarwal RK. Functional vision with bilateral ReZoom® and ReSTOR® intraocular lenses 6 months after cataract surgery. J Cataract Refract Surg. 2007;33:2057-2061.
16. Leyland M, Pringle E. Multifocal versus monofocal intraocular lenses after cataract extraction. Cochrane Database Syst Rev. 2006 Oct 18;(4): CD003169.
17. Lafuma A, Berdeaux G. Modelling lifetime cost consequences of ReSTOR® for presbyopia in four European countries. Eye. 2009;23:1072-1080.
18. Lafuma A, Berdeaux G. Modelling lifetime cost consequences of ReSTOR® in cataract surgery in four European countries. BMC Ophthalmol. 2008;15:8-12.
19. Reflection paper on the regulatory guidance for the use of Health-Related Quality of Life (HRQL) measures in the evaluation of medicinal products, Draft, EMEA, 18th November, 2004. Available from: http://www.emea.eu.int/pdfs/human/ewp/13939104en.pdf.
20. Guidance for Industry Patient-Reported Outcome measures: Use in medical product development to support labeling claims, Draft guidance, FDA, February 2006. Available from: http://www.fda.gov/cder/guidance/5460dft.htm.
21. Chassany O, Sagnier P, Marquis P, Fullerton S, Aaronson N; For the European Regulatory Issues on quality of life assessment group. Patient reported outcomes: the example of health-related quality of life. A European guidance document for the improved integration of health-related quality of of life assessment in the drug regulatory process. Drug inf J. 2002;36:209-238.
22. Hjelmgren J, Berggren F, Andersson F. Health economic guidelinessimilarities, differences and some implications. Value Health. 2001;4:225-250.
23. ©). BMC Ophthalmology. In press.
24. ©). J Refract Surg. In press.
25. Meunier J, Berdeaux G, Arnould B, Viala-Danten M. Scoring and psychometric validation of the Freedom from Spectacles Value Scale (FGVS) [Abstract]. International Society for PharmacoEconomics and Outcome Research. Value Health. 2008;11:A625.
26. ©). [Abstract]. International Society for PharmacoEconomics and Outcome Research. Value Health. 2008;11:A296.
27. Glover F, Laguna M. Tabu Search. Boston: Kluwer Academic Publishers; 1997.
28. Friedman N, Goldszmidt M. Learning Bayesian networks with local structure. In: Eric Horvitz and Finn V. Jensen, eds. Proceedings of the Twelfth Conference on Uncertainty in Artificial Intelligence. Morgan Kaufmann; 1996:252-262.
29. Vingolo EM, Grenga P, Iacobelli L, Grenga R. Visual acuity and contrast sensitivity: AcrySof ReSTOR® apodized diffractive versus AcrySof SA60AT monofocal intraocular lenses. J Cataract Refract Surg. 2007;33:1244-1247.
30. Sallet G. Refractive outcome after bilateral implantation of an apodized diffractive intraocular lens. Bull Soc Belge Ophtalmol. 2006;299:67-73.
31. Alfonso JF, Fernández-Vega L, Baamonde MB, Montés-Micó R. Prospective visual evaluation of apodized diffractive intraocular lenses. J Cataract Refract Surg. 2007;33:1235-1243.
32. de Vries NE, Webers CA, Montés-Micó R, et al. Long-term follow-up of a multifocal apodized diffractive intraocular lens after cataract surgery. J Cataract Refract Surg. 2008;34:1476-1482.
33. Cuq C, Lafuma A, Jeanbat V, Berdeaux G. A European survey of patient satisfaction with spectacles after cataract surgery and the associated costs in four European countries (France, Germany, Spain, and Italy). Ophthalmic Epidemiol. 2008;15:234-241.
34. Lafuma A, Berdeaux G. Modeling lifetime cost consequences of ReSTOR® in cataract surgery in four European countries. BMC Ophthalmology. 2008;8:12.
35. OECD Health Data 2007. Statistics and Indicators for 30 Countries. Paris, France: OECD Publishing; 2007.
36. Beresniak A, Duru G. Economie de la santé, Masson, 5ème édition; 2001:19-21.